LINDSAY BEALOR GREENLEAF TALKS TO PINK SHEET ABOUT THE PRESIDENT’S PENDING DRUG PRICING ANNOUNCEMENT
“Many of the policies would need to be implemented through legislation – and it would be difficult to generate enough bipartisan support to get such measures through Congress at this point – or they could be the subject of payment demonstrations conducted under the auspices of the CMS Center for Medicare and Medicaid Innovation, ADVI’s Director Lindsay Bealor Greenleaf pointed out. CMMI has broad authority to experiment with new models under Medicare because the law does not restrict the duration, geographic scope or number of beneficiaries covered by a demonstration, as long as it is not national in scope," she noted.
[el-text]
LINDSAY BEALOR GREENLEAF TALKS TO PINK SHEET ABOUT THE PRESIDENT’S PENDING DRUG PRICING ANNOUNCEMENT
Written by Cathy Kelly
***excerpt***
“Many of the policies would need to be implemented through legislation – and it would be difficult to generate enough bipartisan support to get such measures through Congress at this point – or they could be the subject of payment demonstrations conducted under the auspices of the CMS Center for Medicare and Medicaid Innovation, ADVI’s Director Lindsay Bealor Greenleaf pointed out. CMMI has broad authority to experiment with new models under Medicare because the law does not restrict the duration, geographic scope or number of beneficiaries covered by a demonstration, as long as it is not national in scope,” she noted.
***end excerpt***
***
[/el-text]
View full article here
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.